Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil
Authors:
- Cibele C CésarCCCibele C César
- Francisco A AcúrcioFAFrancisco A Acúrcio
- Maria das Graças B. CeccatoMCMaria das Graças B. Ceccato
- Cristiane A Menezes de PáduaCPCristiane A Menezes de Pádua
- Juliana ÁlvaresJÁJuliana Álvares
- Lorenza N CamposLCLorenza N Campos
- Ricardo A CarmoRCRicardo A Carmo
- Mark Dc GuimarãesMGMark Dc Guimarães
- 1 October 2005
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 19 (Suppl 4) , S5-S13
Abstract
To assess the incidence, magnitude and factors associated with the first episode of non-adherence for 12 months after the first antiretroviral prescription. A prospective study of HIV-infected patients receiving their first antiretroviral prescription in public referral centers, Belo Horizonte, Brazil. Baseline assessment occurred at the moment of the first prescription and follow-up visits at the first, fourth and seventh month, from May 2001 to May 2003. Non-adherence was self-reported and defined as the intake of less than 95% of the prescribed doses for 3 days before the follow-up interviews. Cumulative and person-time incidence were estimated and Cox's proportional model was used to assess the relative hazard (RH) of non-adherence with 95% confidence interval for both univariate and multivariate analysis. Among 306 patients, the cumulative incidence of non-adherence was 36.9% (incidence rate 0.21/100 person-days). Multivariate analysis (P < 0.05) showed that unemployment (RH = 2.17), alcohol use (RH = 2.27), self-report of three or more adverse reactions (RH = 1.64), number of pills per day (RH = 2.04), switch in antiretroviral regimen (RH = 2.72), and a longer time between the HIV test result and the first antiretroviral prescription (RH = 2.27) were associated with an increased risk of non-adherence, whereas the use of more than one health service indicated a negative association (RH = 0.54). The current analysis has pointed out the importance of clinical and health service characteristics as potential indicators of non-adherence after initiating therapy. Early assessment and intervention strategies should be priorities in these AIDS public referral centres. Feasible and reliable indicators for the routine monitoring of adherence should be incorporated in clinical practice.Keywords
This publication has 16 references indexed in Scilit:
- Multiple Validated Measures of Adherence Indicate High Levels of Adherence to Generic HIV Antiretroviral Therapy in a Resource-Limited SettingJAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Highly active antiretroviral therapy in Brazil: the challenge of universal access in a context of social inequality.Revista Panamericana de Salud Pública, 2004
- Antiretroviral treatment in resource-poor settingsAIDS, 2004
- Antiretroviral therapy adherence in BrazilAIDS, 2004
- An assessment of current HIV treatment adherence services in the UKAIDS Care, 2002
- Patient adherence to HIV medication regimens: a review of published and abstract reportsPatient Education and Counseling, 2002
- La non-observance des patients infectés par le VIH, soutenus par une association communautaireSanté Publique, 2001
- Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAARTHIV Research & Clinical Practice, 2001
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Potential factors affecting adherence with HIV therapyAIDS, 1997